OREANDA-NEWS. June 14, 2016. Eli Lilly and Company (NYSE: LLY) today announced the promotion of

Aarti Shah, Ph.D., to senior vice president and chief information officer effective July 1. She has been the global brand development leader for immunology since 2013.

Shah joined Lilly in 1994 as a senior statistician after completing her doctorate in applied statistics from the University of California, Riverside. During her career at Lilly, she has held many technical and administrative leadership positions, both in the United States and abroad, including serving as vice president for biometrics and advanced analytics and as executive director of global information sciences.

In her new role, she will lead the efforts of a worldwide IT organization with more than 1,300 employees, in addition to many contractors and external business partners, to deliver innovative IT solutions to the business. She will report to

Derica Rice, Lilly's executive vice president of Global Services and chief financial officer. 

"As a visionary and inspirational leader, Aarti has a proven track record of building strong, flexible and sustainable organizations. She is known for her relentless focus and passion for developing people. And her deep knowledge of drug development will be vital as IT touches every aspect of our business," Rice said.

"I want to create an environment in which IT enables and brings innovative solutions to business transformations across Lilly's entire drug development value chain from discovery to commercial.  I hope to do this by unleashing the potential of our employees and by building strong internal and external collaborations and thus play a critical role in bringing Lilly's mission to life," Shah said.

Shah serves on the board of directors for the Indianapolis Public Library Foundation and Center for Interfaith Cooperation and on the Executive Advisory Council for the Healthcare Businesswoman'sAssociation (HBA) Indiana Chapter. She received the 2011 Rising Star Award from Healthcare Businesswoman's Association (HBA).

About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels.